We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
-3.18%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
AUM
$1.57B
AUM Growth
-$118M
Cap. Flow
-$42.5M
Cap. Flow %
-2.71%
Top 10 Hldgs %
17.86%
Holding
854
New
57
Increased
321
Reduced
405
Closed
55
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMNB icon
776
Farmers National Banc Corp
FMNB
$952M
$131K 0.01%
11,330
-364
-3% -$4.65K
RLGT icon
777
Radiant Logistics
RLGT
$391M
$130K 0.01%
+22,962
New +$156K
NFBK
778
DELISTED
Northfield Bancorp
NFBK
$126K 0.01%
13,293
-425
-3% -$4.65K
GTES icon
779
Gates Industrial Corporation Ltd.
GTES
$7.2B
$117K 0.01%
+10,054
New +$125K
GGN
780
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$836M
$113K 0.01%
30,904
-119
-0.4% -$447
IRWD icon
781
Ironwood Pharmaceuticals
IRWD
$711M
$111K 0.01%
11,516
-210
-2% -$2.06K
PLTK icon
782
Playtika
PLTK
$1.02B
$109K 0.01%
+11,354
New +$122K
PCQ
783
Pimco California Municipal Income Fund
PCQ
$168M
$109K 0.01%
+13,099
New +$125K
FFWM
784
DELISTED
First Foundation Inc
FFWM
$106K 0.01%
17,424
-383
-2% -$2.52K
SB icon
785
Safe Bulkers
SB
$746M
$94.4K 0.01%
29,145
-129
-0.4% -$416
PHD
786
DELISTED
Pioneer Floating Rate Fund
PHD
$90.6K 0.01%
10,059
-306
-3% -$2.75K
BTAI icon
787
BioXcel Therapeutics
BTAI
$28.8M
$85.9K 0.01%
2,121
+1,002
+90% +$101K
NVAX icon
788
Novavax
NVAX
$1.31B
$83.8K 0.01%
11,580
+459
+4% +$3.67K
MCHB
789
Mechanics Bancorp
MCHB
$3.8B
$83.5K 0.01%
10,722
-12,099
-53% -$107K
BGFV
790
DELISTED
Big 5 Sporting Goods
BGFV
$70.6K ﹤0.01%
10,068
-31
-0.3% -$258
BYSI icon
791
BeyondSpring
BYSI
$32.5M
$64.8K ﹤0.01%
80,993
-15,990
-16% -$15.6K
TSVT
792
DELISTED
2seventy bio
TSVT
$63.7K ﹤0.01%
16,238
-3,206
-16% -$21K
INO icon
793
Inovio Pharmaceuticals
INO
$79.1M
$63.6K ﹤0.01%
13,630
-2,691
-16% -$14.9K
NGM
794
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$61.9K ﹤0.01%
57,867
+2,298
+4% +$4.75K
NWG icon
795
NatWest
NWG
$75.8B
$58.4K ﹤0.01%
10,009
-1,822
-15% -$11K
ADCT icon
796
ADC Therapeutics
ADCT
$150M
$51.9K ﹤0.01%
57,867
+2,298
+4% +$3.06K
NKTR icon
797
Nektar Therapeutics
NKTR
$2.55B
$43.7K ﹤0.01%
4,888
-964
-16% -$9.28K
TIL icon
798
Instil Bio
TIL
$50.8M
$42K ﹤0.01%
4,904
+195
+4% +$1.97K
ARBK
799
Argo Blockchain
ARBK
$42.3M
$35.2K ﹤0.01%
163
AEG icon
800
Aegon
AEG
$13.9B
-10,057
Closed -$51K

Similar funds

Hennion & Walsh Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, Hennion & Walsh Asset Management held 854 positions worth $1.57B, down 7% from $1.69B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Hennion & Walsh Asset Management's Q3 2023 filing shows 57 new, 321 increased, 405 reduced and 55 closed positions. Its largest new stake was WisdomTree Trust WisdomTree US SmallCap Quality Dividend Growth Fund: 474,056 shares worth $19.5M. The largest sale was Schwab US Dividend Equity ETF, an estimated $20.5M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Financials and Technology.

  • Hennion & Walsh Asset Management's largest Q3 2023 buy was WisdomTree Trust WisdomTree US SmallCap Quality Dividend Growth Fund: 474,056 shares worth $19.5M.
  • Hennion & Walsh Asset Management added most to Nuveen Municipal Credit Income Fund in Q3 2023, an estimated $2.51M increase.
  • Hennion & Walsh Asset Management's biggest Q3 2023 reduction was Schwab US Dividend Equity ETF, cutting an estimated $20.5M.
  • Hennion & Walsh Asset Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $4.42M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 18% of its $1.57B portfolio in Q3 2023.
  • Hennion & Walsh Asset Management opened 57 new positions and closed 55 in Q3 2023.
  • Hennion & Walsh Asset Management's portfolio value fell 7% quarter-over-quarter to $1.57B.

Based on Hennion & Walsh Asset Management's 13F filing for Q3 2023, filed 27 Oct 2023.